Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Agenus Inc., 3 years.
Agenus Inc.
Director · See Remarks
MiNK Therapeutics Inc.
Director
Chief executive roles
Agenus Inc.
· Chairman and CEO
Dates unknown
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Agenus Inc. June 16, 202668.6%
-
Agenus Inc. June 12, 202394.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Agenus Inc. | Grant or award | +4,852 | $3.35 | $16,254 |
| Jun 26, 2026 | Agenus Inc. | Grant or award | +5,364 | $3.03 | $16,253 |
| Jun 12, 2026 | Agenus Inc. | Grant or award | +4,925 | $3.30 | $16,253 |
| May 29, 2026 | Agenus Inc. | Grant or award | +4,644 | $3.50 | $16,254 |
| May 15, 2026 | Agenus Inc. | Grant or award | +4,540 | $3.58 | $16,253 |
| May 1, 2026 | Agenus Inc. | Grant or award | +4,233 | $3.84 | $16,255 |
| Apr 17, 2026 | Agenus Inc. | Grant or award | +3,403 | $4.79 | $16,300 |
| Apr 3, 2026 | Agenus Inc. | Grant or award | +4,629 | $3.33 | $15,415 |
| Mar 20, 2026 | Agenus Inc. | Grant or award | +3,983 | $3.71 | $14,777 |
| Mar 6, 2026 | Agenus Inc. | Grant or award | +4,994 | $2.96 | $14,782 |
| Feb 20, 2026 | Agenus Inc. | Grant or award | +4,829 | $3.06 | $14,777 |
| Feb 6, 2026 | Agenus Inc. | Grant or award | +5,027 | $2.94 | $14,779 |
| Jan 23, 2026 | Agenus Inc. | Grant or award | +4,562 | $3.24 | $14,781 |
| Jan 9, 2026 | Agenus Inc. | Grant or award | +3,780 | $3.91 | $14,780 |
| Dec 26, 2025 | Agenus Inc. | Grant or award | +4,942 | $3.31 | $16,358 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.